Redoxis AB

CRO and research biotech focused on autoimmune conditions

[Redoxis AB @redoxisab]

Our project REDOXIT was made possible thanks to #H2020 #InvestEUresearch !

[Redoxis AB @redoxisab]

Attending #bioeurope in cologne. Interesting opportunities for partnering.

[Redoxis AB @redoxisab]

#BioEurope to meet sponsors for Redoxis preclinical capacities for autoimmune conditions and #ProNoxis development NOX2 lead compounds.

[Iris Öhrn @OhrnIris]

@BRGGothenburg @redoxisab @investinskane

[Medicon Village @MediconVillage]

From startup to spin out @MediconVillage #trulytranslational#readgleaddiscovery

[Abcam @abcam]

Want to attend the world’s leading immunology event? Last chance to win a £1000 travel grant for @ImmunologyAAI 2016 https://t.co/YUESQ300vQ

[Redoxis AB @redoxisab]

@OhrnIris Thanks for great picture from ssbbs in Zürich

[Iris Öhrn @OhrnIris]

SSBBS 10th @redoxisab @BRGGothenburg

[Redoxis AB @redoxisab]

Attending #NLS, these days taking place in #Stockholm 9-10 September- 2015. An event for discussion with partners for next call to #H2020.

[Redoxis AB @redoxisab]

Redoxis has been approved by the French authorities as eligible for French tax reduction for services performed by Redoxis.

[Redoxis AB @redoxisab]

Granted #Eurostars project with #ImageAnalyses to improve and assist development of treatments for #autoimmunity.

[Redoxis AB @redoxisab]

On 23 & 24 September 2015, #NEURINOX holds a Symposium on novel treatment on #ALS, #epilepsy and #MS, se more https://t.co/amsJFV2ZON.

[Redoxis AB @redoxisab]

Swedish Innovation Agency (Vinnova) have granted us funds for establishment of improved preclinical models of SLE
http://t.co/1Qe380SzTf

[Redoxis AB @redoxisab]

@redoxisab For more info, see http://t.co/NwqCl76XBR

[Redoxis AB @redoxisab]

Redoxis is awarded support from #Vinnova to validate and establish preclinical #SLE models to assist in development of new #therapies.

[Redoxis AB @redoxisab]

#Redoxis attending one of the most important events in #pharmaceutical industry - the annual partnering meeting #BioEurope.

[Redoxis AB @redoxisab]

@Lundsuni publish evidence between low ROS and increased SLE severity #http://arthritis-research.com/content/16/3/R120.

[Redoxis AB @redoxisab]

#Redoxis will participate in the partnering event #NLS in Stockholm during 7-9 September.

[Redoxis AB @redoxisab]

@redoxisab More information about our collaboration with #AstonUniversity and Helen Griffiths can be found at http://t.co/hOW6nQsJP4

[Redoxis AB @redoxisab]

Part of #Redoxis collaboration with professor Griffiths at #AstonUniversity, UK, we have now published our first joint publication.